nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—sarcoma	0.901	1	CbGaD
Masoprocol—LTB4R—hematopoietic system—sarcoma	0.00291	0.0605	CbGeAlD
Masoprocol—IGF1R—embryo—sarcoma	0.0027	0.056	CbGeAlD
Masoprocol—LTB4R—skin of body—sarcoma	0.00253	0.0526	CbGeAlD
Masoprocol—IGF1R—hematopoietic system—sarcoma	0.00241	0.05	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—TEK—sarcoma	0.00235	0.0501	CbGpPWpGaD
Masoprocol—IGF1R—connective tissue—sarcoma	0.00232	0.0481	CbGeAlD
Masoprocol—IGF1R—smooth muscle tissue—sarcoma	0.00212	0.044	CbGeAlD
Masoprocol—IGF1R—skin of body—sarcoma	0.00209	0.0434	CbGeAlD
Masoprocol—LTB4R—lymphoid tissue—sarcoma	0.00205	0.0426	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Epirubicin—sarcoma	0.00196	0.519	CbGdCrCtD
Masoprocol—LTB4R—bone marrow—sarcoma	0.00187	0.0388	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—sarcoma	0.00181	0.481	CbGdCrCtD
Masoprocol—IGF1R—lymphoid tissue—sarcoma	0.00169	0.0352	CbGeAlD
Masoprocol—LTB4R—testis—sarcoma	0.0016	0.0332	CbGeAlD
Masoprocol—LTB4R—liver—sarcoma	0.00151	0.0314	CbGeAlD
Masoprocol—CYP19A1—Ovarian Infertility Genes—GJA4—sarcoma	0.00143	0.0305	CbGpPWpGaD
Masoprocol—CYP2J2—skin of body—sarcoma	0.00142	0.0294	CbGeAlD
Masoprocol—IGF1R—testis—sarcoma	0.00132	0.0274	CbGeAlD
Masoprocol—ALOX5—hematopoietic system—sarcoma	0.00128	0.0267	CbGeAlD
Masoprocol—IGF1R—liver—sarcoma	0.00125	0.0259	CbGeAlD
Masoprocol—CYP2J2—cardiac atrium—sarcoma	0.00124	0.0257	CbGeAlD
Masoprocol—ALOX5—connective tissue—sarcoma	0.00124	0.0257	CbGeAlD
Masoprocol—CYP2J2—uterus—sarcoma	0.00123	0.0256	CbGeAlD
Masoprocol—LTB4R—lymph node—sarcoma	0.00116	0.024	CbGeAlD
Masoprocol—ALOX5—smooth muscle tissue—sarcoma	0.00113	0.0235	CbGeAlD
Masoprocol—CYP2J2—tendon—sarcoma	0.00108	0.0224	CbGeAlD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PLCG1—sarcoma	0.00103	0.0219	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—PDGFRB—sarcoma	0.000958	0.0205	CbGpPWpGaD
Masoprocol—IGF1R—lymph node—sarcoma	0.000956	0.0198	CbGeAlD
Masoprocol—ALOX5—lymphoid tissue—sarcoma	0.000905	0.0188	CbGeAlD
Masoprocol—CYP2J2—testis—sarcoma	0.000894	0.0186	CbGeAlD
Masoprocol—CYP19A1—hematopoietic system—sarcoma	0.000888	0.0184	CbGeAlD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000855	0.0183	CbGpPWpGaD
Masoprocol—CYP19A1—connective tissue—sarcoma	0.000855	0.0178	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—NRAS—sarcoma	0.000847	0.0181	CbGpPWpGaD
Masoprocol—CYP2J2—liver—sarcoma	0.000845	0.0175	CbGeAlD
Masoprocol—ALOX5—bone marrow—sarcoma	0.000824	0.0171	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—KDR—sarcoma	0.000794	0.017	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—KDR—sarcoma	0.000743	0.0159	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—HBA1—sarcoma	0.000742	0.0159	CbGpPWpGaD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—KRAS—sarcoma	0.000729	0.0156	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—FOXO1—sarcoma	0.000728	0.0156	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PDGFRB—sarcoma	0.000726	0.0155	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PDGFRA—sarcoma	0.000715	0.0153	CbGpPWpGaD
Masoprocol—ALOX5—testis—sarcoma	0.000704	0.0146	CbGeAlD
Masoprocol—CYP19A1—uterus—sarcoma	0.000671	0.0139	CbGeAlD
Masoprocol—IGF1R—Focal Adhesion—VEGFC—sarcoma	0.000666	0.0142	CbGpPWpGaD
Masoprocol—ALOX5—liver—sarcoma	0.000666	0.0138	CbGeAlD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—CTNNB1—sarcoma	0.000643	0.0138	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—CREB1—sarcoma	0.000628	0.0134	CbGpPWpGaD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—HRAS—sarcoma	0.00062	0.0132	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—FOXO1—sarcoma	0.000596	0.0127	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000593	0.0127	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—sarcoma	0.000578	0.0124	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00057	0.0122	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—HRAS—sarcoma	0.000536	0.0115	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—FLT1—sarcoma	0.000533	0.0114	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—SRC—sarcoma	0.000522	0.0112	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL2—sarcoma	0.000515	0.011	CbGpPWpGaD
Masoprocol—ALOX5—lymph node—sarcoma	0.00051	0.0106	CbGeAlD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—EGFR—sarcoma	0.00051	0.0109	CbGpPWpGaD
Masoprocol—CYP2J2—Tryptophan metabolism—MDM2—sarcoma	0.000509	0.0109	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000491	0.0105	CbGpPWpGaD
Masoprocol—CYP19A1—testis—sarcoma	0.000487	0.0101	CbGeAlD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000463	0.0099	CbGpPWpGaD
Masoprocol—CYP19A1—liver—sarcoma	0.00046	0.00956	CbGeAlD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—sarcoma	0.000458	0.00979	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—JUN—sarcoma	0.000451	0.00965	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—VEGFA—sarcoma	0.000437	0.00935	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—MDM2—sarcoma	0.000437	0.00933	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—CREB1—sarcoma	0.000433	0.00925	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—NRAS—sarcoma	0.000432	0.00924	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MDM2—sarcoma	0.000428	0.00916	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—FOXO1—sarcoma	0.000426	0.00911	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—SRC—sarcoma	0.00042	0.00899	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000417	0.00892	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—VEGFA—sarcoma	0.000409	0.00875	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—SRC—sarcoma	0.000405	0.00866	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—VEGFA—sarcoma	0.000404	0.00864	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000397	0.00848	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—EGFR—sarcoma	0.000394	0.00842	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CCND1—sarcoma	0.00038	0.00813	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—JUN—sarcoma	0.000372	0.00796	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—KRAS—sarcoma	0.000372	0.00795	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PDGFRB—sarcoma	0.000371	0.00793	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—sarcoma	0.000369	0.0079	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—sarcoma	0.000368	0.00786	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PDGFRA—sarcoma	0.000365	0.0078	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MYC—sarcoma	0.000363	0.00776	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—MDM2—sarcoma	0.000358	0.00766	CbGpPWpGaD
Masoprocol—CYP19A1—lymph node—sarcoma	0.000353	0.00733	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—IL2—sarcoma	0.000343	0.00733	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—SRC—sarcoma	0.00034	0.00728	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CCND1—sarcoma	0.000334	0.00715	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—NRAS—sarcoma	0.000327	0.007	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—HRAS—sarcoma	0.000316	0.00676	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—JUN—sarcoma	0.000311	0.00666	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—KDR—sarcoma	0.000307	0.00657	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—NRAS—sarcoma	0.000307	0.00656	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCR4—sarcoma	0.000302	0.00646	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MYC—sarcoma	0.000299	0.0064	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—NRAS—sarcoma	0.000299	0.00639	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EGFR—sarcoma	0.000298	0.00638	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.000287	0.00614	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—HRAS—sarcoma	0.000285	0.00609	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—KRAS—sarcoma	0.000282	0.00603	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—SRC—sarcoma	0.000279	0.00597	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—SRC—sarcoma	0.000279	0.00597	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MYC—sarcoma	0.000268	0.00573	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—KRAS—sarcoma	0.000264	0.00564	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—EGFR—sarcoma	0.000262	0.00561	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—KRAS—sarcoma	0.000257	0.0055	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—sarcoma	0.000251	0.00536	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—sarcoma	0.000246	0.00525	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—HRAS—sarcoma	0.00024	0.00512	CbGpPWpGaD
Masoprocol—CYP19A1—Tryptophan metabolism—MDM2—sarcoma	0.000234	0.005	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—HRAS—sarcoma	0.000224	0.0048	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—JUN—sarcoma	0.000222	0.00475	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—sarcoma	0.00022	0.00471	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—HRAS—sarcoma	0.000219	0.00467	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—sarcoma	0.000206	0.00439	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000201	0.00431	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—HRAS—sarcoma	0.000197	0.0042	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—sarcoma	0.000194	0.00415	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—JUN—sarcoma	0.000194	0.00414	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CTNNB1—sarcoma	0.000192	0.00411	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000178	0.00381	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—SRC—sarcoma	0.000174	0.00372	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCR4—sarcoma	0.000171	0.00365	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—sarcoma	0.000169	0.00362	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000162	0.00347	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCR4—sarcoma	0.000155	0.00332	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000153	0.00328	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—sarcoma	0.000152	0.00326	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.00015	0.00322	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TLE1—sarcoma	0.000144	0.00307	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—HRAS—sarcoma	0.00014	0.003	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.00013	0.00279	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—HRAS—sarcoma	0.000122	0.00262	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TLE1—sarcoma	0.000122	0.00261	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFC—sarcoma	0.000121	0.00259	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000109	0.00233	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFC—sarcoma	0.000103	0.00221	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FLT1—sarcoma	9.7e-05	0.00207	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLCG1—sarcoma	9.53e-05	0.00204	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCR4—sarcoma	9.16e-05	0.00196	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ATF1—sarcoma	9.06e-05	0.00194	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	9.03e-05	0.00193	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO2—sarcoma	8.39e-05	0.00179	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HBA1—sarcoma	8.33e-05	0.00178	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CREB1—sarcoma	8.31e-05	0.00178	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FLT1—sarcoma	8.25e-05	0.00176	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLCG1—sarcoma	8.11e-05	0.00173	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	7.86e-05	0.00168	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	7.85e-05	0.00168	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCR4—sarcoma	7.79e-05	0.00167	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	7.79e-05	0.00166	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ATF1—sarcoma	7.7e-05	0.00165	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO2—sarcoma	7.48e-05	0.0016	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HBA1—sarcoma	7.43e-05	0.00159	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLCG1—sarcoma	7.12e-05	0.00152	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1R—sarcoma	7.11e-05	0.00152	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	6.86e-05	0.00147	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FOXO1—sarcoma	6.77e-05	0.00145	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—sarcoma	6.76e-05	0.00145	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDGFRB—sarcoma	6.75e-05	0.00144	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDGFRA—sarcoma	6.65e-05	0.00142	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLCG1—sarcoma	6.34e-05	0.00136	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	6.31e-05	0.00135	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	6.17e-05	0.00132	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—sarcoma	6.14e-05	0.00131	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	5.83e-05	0.00125	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FOXO1—sarcoma	5.75e-05	0.00123	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDGFRB—sarcoma	5.74e-05	0.00123	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDGFRA—sarcoma	5.65e-05	0.00121	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—sarcoma	5.6e-05	0.0012	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	5.18e-05	0.00111	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KIT—sarcoma	5.15e-05	0.0011	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—NRAS—sarcoma	5.15e-05	0.0011	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CREB1—sarcoma	4.91e-05	0.00105	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—sarcoma	4.76e-05	0.00102	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—sarcoma	4.7e-05	0.001	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—sarcoma	4.44e-05	0.000949	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KIT—sarcoma	4.38e-05	0.000937	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CREB1—sarcoma	4.17e-05	0.000892	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MDM2—sarcoma	4.06e-05	0.000868	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO2—sarcoma	3.85e-05	0.000823	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HBA1—sarcoma	3.83e-05	0.000818	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—sarcoma	3.77e-05	0.000806	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—sarcoma	3.63e-05	0.000776	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—sarcoma	3.54e-05	0.000756	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JUN—sarcoma	3.53e-05	0.000754	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CTNNB1—sarcoma	3.5e-05	0.000749	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MDM2—sarcoma	3.45e-05	0.000738	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLCG1—sarcoma	3.27e-05	0.000699	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—sarcoma	3.17e-05	0.000677	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—sarcoma	3.08e-05	0.000659	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—sarcoma	3.08e-05	0.000659	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NRAS—sarcoma	3.05e-05	0.000651	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—sarcoma	3.01e-05	0.000643	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JUN—sarcoma	3e-05	0.000641	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CTNNB1—sarcoma	2.98e-05	0.000637	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—sarcoma	2.84e-05	0.000606	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—sarcoma	2.77e-05	0.000593	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—sarcoma	2.69e-05	0.000575	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—sarcoma	2.62e-05	0.00056	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—sarcoma	2.62e-05	0.00056	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NRAS—sarcoma	2.59e-05	0.000554	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—sarcoma	2.41e-05	0.000516	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—sarcoma	2.36e-05	0.000504	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—sarcoma	2.33e-05	0.000498	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—sarcoma	2.23e-05	0.000476	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—sarcoma	2.23e-05	0.000476	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—sarcoma	1.98e-05	0.000423	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—sarcoma	1.89e-05	0.000405	CbGpPWpGaD
